Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Zeposia® (ozanimod) – New indication
May 27, 2021 - Bristol Myers Squibb announced the FDA approval of Zeposia (ozanimod), for the treatment of moderately to severely active ulcerative colitis (UC) in adults.
